Apr 8, 2018 | Featured, Research News, Technology Updates
Eli Lilly ponies up $63M for Sigilon’s diabetes cell therapies, according to Amirah Al Adrus of FierceBiotech.com, 4 April 2018. Eli Lilly is continuing its push into new diabetes products, paying $63 million up front to get its hands on Sigilon Therapeutics’...
Apr 2, 2018 | Recommended Books
Well, the title tagline says it all: A Survival Guide. “Here is a given: 100% of people do not like having diabetes. Most partners don’t wish to burden anyone with their disease 1, especially not their significant other. Often, the...
Mar 29, 2018 | Featured, Technology Updates
Dexcom G6 cleared by FDA with no fingerstick calibrations 10-day wear time approval for ages 2 years and older no acetaminophen interference and more The FDA just cleared the Dexcom G6 CGM today, only six months after it was submitted to the FDA and far earlier...